Megan Reinhardt is the Co-Founder and Chief Executive Officer of RAE Health. She is also the CO-PI for a current fast track grant awarded by the NIH, named "RAE (Realize, Analyze, Engage")- A Digital Biomarker Based Detection and Intervention system for Stress and Craving During Recovery from Substance Abuse Disorders." She has held various executive positions, in publicly traded, start-up and private sectors. Her most recent position was Vice President for a clinical laboratory based in Charlotte, NC. There she was responsible in overseeing operations for two clinical laboratory locations, payor contracting and acquisitions. As a problem solver who is driven to create efficient solutions and services that positively impact society. Her passion and ultimate goal is to reduce suffering, stigma and relapse rates for individuals afflicted with substance use disorder.